• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD MEDICAL DIAGNOSTICS GMBH ERYTYPE S ABD+REV A1,B

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD MEDICAL DIAGNOSTICS GMBH ERYTYPE S ABD+REV A1,B Back to Search Results
Catalog Number 806127100
Device Problems No Display/Image (1183); False Positive Result (1227); Defective Device (2588)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/13/2018
Event Type  malfunction  
Manufacturer Narrative
This is our initial report on this incident.
 
Event Description
The customer reported that she is unable to pass qc because she is seeing globs in the images instead of clearly negative results in the reverse typing when using erytype s abd+rev a1,b on tango optimo.Due to the globs in the reverse typing the reactions were interpreted as positives by the tango optimo when the reactions were supposed to be negative.Due to the discrepancy between forward and reverse typing the tango optimo did not show a blood group and no incorrect results were released.The customer returned the complaint sample of erytype s abd+rev a1,b for further investigation but not the patient samples that had caused false positive test results.Testing in our quality control laboratory is still ongoing.A review of the batch record documentation showed no irregularities which might have negative influences on the quality of the allegedly defective lot.The sent result image shows a light red background around a dark red spot in the reverse a1- and b-cell wells.This spot is not a normal agglutination, but looks rather like hemolysis, which has led to discrepant overall result of the ab rh d positive quality control sample.The instrument's software flagged this sample as discrepant and did not give an overall result out.The last bi-annual preventive maintenance was performed on (b)(6) 2018.No log files are present for evaluation as the customer refused to allow access to files.The affected tango optimo was inspected by our field service engineers.They confirmed the issue, and verified the orbital shaker.Sample syringe and valve were replaced, and reagent syringes were replaced as well.The problem continued until on board plates were replaced with new plates.Performed post service verification procedure, as required.Instrument is operating within manufacturer specification and returned to full operation.
 
Manufacturer Narrative
This is our final report on this incident.
 
Event Description
The customer reported that she is unable to pass qc because she is seeing globs in the images instead of clearly negative results in the reverse typing when using erytype s abd+rev a1,b on tango optimo.Due to the globs in the reverse typing the reactions were interpreted as positives by the tango optimo when the reactions were supposed to be negative.Due to the discrepancy between forward and reverse typing the tango optimo did not show a blood group and no incorrect results were released.The customer returned the complaint product sample for further investigation but not the patient samples that had caused false positive test results.Therefore our quality control laboratory tested the four erytype plates submitted by the customer with different donor samples.All positive and negative reactions were correct.We did not observe any globs in the reverse typing.Testing by our quality control laboratory confirmed that the allegedly defective lot of erytypecell a1&b functions correctly.A review of the batch record documentation showed no irregularities which might have negative influences on the quality of the allegedly defective lot.Result pictures were available and reviewed: the result image shows a light red background around a dark red spot in the reverse a1- and b-cell wells.This spot is not a normal agglutination, but looks rather like hemolysis, which has led to discrepant overall result of the ab rh d positive quality control sample.The instrument's software flagged this sample as discrepant and did not give an overall result out.The last bi-annual preventive maintenance was performed on 09/13/2018.No log files are present for evaluation as the customer refused to allow access to files.The affected tango optimo was inspected by our field service engineers.They confirmed the issue, and verified the orbital shaker.Sample syringe and valve were replaced, and reagent syringes were replaced as well.The problem continued until on board plates were replaced with new plates.Performed post service verification procedure, as required.Instrument is operating within manufacturer specification and returned to full operation.No indication for an instrument malfunction could be identified on current information.Log files and samples were not made available and qc testing showed results as expected.But as stated by the engineer, replacement with other erytype plates resolved the problem.The actions performed during the service intervention may also have contributed to the resolution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ERYTYPE S ABD+REV A1,B
Type of Device
ERYTYPE S ABD+REV A1,B
Manufacturer (Section D)
BIO-RAD MEDICAL DIAGNOSTICS GMBH
industriestrasse 1
dreieich, hessen 63303
GM  63303
MDR Report Key8234839
MDR Text Key134584212
Report Number9610824-2018-00091
Device Sequence Number1
Product Code KSZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 01/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/25/2019
Device Catalogue Number806127100
Device Lot Number8809190
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/03/2019
Initial Date Manufacturer Received 12/13/2018
Initial Date FDA Received01/10/2019
Supplement Dates Manufacturer Received12/13/2018
Supplement Dates FDA Received01/18/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
TANGO OPTIMO, # 9142400478; TANGO OPTIMO, # 9142400478
-
-